Last updated on March 2018

A clinical trial seeking patients for a research study for the treatment of Parkinson's Disease

Brief description of study

The purpose of this study is to determine whether the gastric retentive Accordion Pill Carbidopa/Levodopa (AP-CD/LD) is more effective than the commercially available immediate release Carbidopa/Levodopa in reducing motor fluctuations such as "off time" in advanced Parkinson's Disease patients.

Detailed Study Description

A multi-center, global, randomized, double-blind, double-dummy, active-controlled, parallel-group study in adult subjects with fluctuating PD. The study will have 2 open label Titration periods of 6 weeks each prior to the double blind Maintenance period. In the open label periods all patients will be stabilized on the active comparator Sinemet and then on AP-CD/LD. The double blind Maintenance period will be 13 weeks long.

Clinical Study Identifier: NCT02605434

Contact Investigators or Research Sites near you

Start Over

Michael Lorrain, MD

Praxis Dr. Lorrain
Dusseldorf, Germany
  Connect »